In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Neumora Therapeutics Inc (NASDAQ: NMRA) was $1.02 for the day, down -6.42% from the previous closing price of $1.09. In other words, the price has decreased by -$6.42 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
Our analysis of NMRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.98 and its Current Ratio is at 8.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Stifel Downgraded its Buy to Hold on March 07, 2025, whereas the target price for the stock was revised from $6 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 12 ’25 when Henry Gosebruch bought 15,000 shares for $1.43 per share.
BERNS PAUL L sold 13,871 shares of NMRA for $23,468 on Feb 18 ’25. The insider now owns 7,405,004 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Milligan Michael Lee, who serves as the insider of the company, sold 1,978 shares for $1.69 each. As a result, the insider received 3,351 and left with 22,470 shares of the company.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $17.19, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 36.24%, while the 200-Day Moving Average is calculated to be -83.37%.
Shares Statistics:
A total of 161.75M shares are outstanding, with a floating share count of 65.21M. Insiders hold about 59.69% of the company’s shares, while institutions hold 28.38% stake in the company.
